Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Recent & Breaking News (GREY:IMVIQ)

IMV Welcomes Marc Jasmin as Senior Director, Investor Relations and Communications

GlobeNewswire December 5, 2018

IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018

GlobeNewswire November 26, 2018

IMV Moves to Develop DPX-Survivac as Monotherapy for Recurrent Ovarian Cancer

GlobeNewswire November 20, 2018

Recent Analysis Shows BioLineRx, Interlink Electronics, IMV INC, PAR Technology, Hudson Global, and Identiv Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire November 16, 2018

IMV Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 15, 2018

Veteran Oncology Biotechnology Executive and Third Rock Ventures Entrepreneur in Residence Markus Warmuth, MD, Joins IMV Inc. Board of Directors

GlobeNewswire November 6, 2018

IMV Inc. Announces Q3 2018 Financial Results and Investor Conference Call Details

GlobeNewswire November 2, 2018

IMV Inc. to Announce Third Quarter 2018 Financial Results and Host Earnings Call on November 2, 2018

GlobeNewswire October 23, 2018

IMV Inc. to Present at Upcoming Investor Conferences

GlobeNewswire October 9, 2018

IMV Provides Update on Progress of its DPX-RSV Program

GlobeNewswire September 27, 2018

IMV Inc. Announces Early Positive Results from Phase 2 Clinical Trial of Lead Candidate DPX-Survivac in Combination with Merck’s Keytruda® in Patients with DLBCL

GlobeNewswire September 18, 2018

IMV Inc. Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA® Across Five Solid Tumor Indications

GlobeNewswire September 11, 2018

IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia

GlobeNewswire September 4, 2018

IMV Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference

GlobeNewswire August 23, 2018

IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial

GlobeNewswire August 9, 2018

IMV Inc. Announces Q2 2018 Financial Results

GlobeNewswire August 8, 2018

IMV Inc. to Announce Second Quarter 2018 Financial Results and Host Earnings Call on August 8, 2018

GlobeNewswire July 31, 2018

IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference

GlobeNewswire July 25, 2018

IMV Inc. Appoints Julia P. Gregory to Board of Directors

GlobeNewswire June 7, 2018

IMV Inc. (Formerly Immunovaccine Inc.) Presents New Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ASCO Meeting

GlobeNewswire June 3, 2018